for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Abbott India Limited

ABOT.NS

Latest Trade

10,999.60INR

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

6,900.00

 - 

11,298.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
10,999.60
Open
--
Volume
--
3M AVG Volume
0.22
Today's High
--
Today's Low
--
52 Week High
11,298.00
52 Week Low
6,900.00
Shares Out (MIL)
21.25
Market Cap (MIL)
233,513.90
Forward P/E
43.03
Dividend (Yield %)
0.45

Next Event

Q2 2020 Abbott India Ltd Earnings Release

Latest Developments

More

Abbott India Dec-Qtr Profit Rises

Abbott India Dec-Qtr Net Profit Rises

Abbott India Sept-qtr profit up 83 pct

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Abbott India Limited

Abbott India Limited is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Its business operations are divided into four business divisions: Women's Health & Gastrointestine, Gastroenterology and Hepatic Care; Specialty Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestine, Gastroenterology and Hepatic Care division has a mix of global and local brands present in the pregnancy, constipation and liver diseases segments. The Specialty Care division consists of a range of products in the treatment of central nervous system and metabolic disorders. The GenNext division focuses on several therapy areas, including pain management, vitamins and pregnancy. Its vaccines include Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present in the over the counter antacid segment.

Industry

Biotechnology & Drugs

Contact Info

3-4 Corporate Park

Sion-Trombay Road, Chembur

+91.22.38162000

http://www.abbott.co.in/

Executive Leadership

Munir Ahmed Shaikh

Non-Executive Independent Chairman of the Board

Rajiv Sonalker

Chief Financial Officer, Additional Whole Time Director

Krupa Anandpara

Compliance Officer, Company Secretary

Ambati Venu

Managing Director, Additional Director

Vishwanath Swarup

Director - Commercial, Sales Excellence and Operations

Key Stats

2.25 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

29.0K

2018

33.0K

2019

36.8K

2020(E)

41.5K
EPS (INR)

2017

132.630

2018

188.810

2019

211.930

2020(E)

255.365
Price To Earnings (TTM)
48.16
Price To Sales (TTM)
6.09
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
45.56
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-Abbott India Dec-Qtr Net Profit Rises

* DEC QUARTER NET PROFIT 1.15 BILLION RUPEES VERSUS PROFIT 855.6 MILLION RUPEES YEAR AGO

BRIEF-Abbott India Sept-qtr profit up 83 pct

* Sept quarter net profit 1.38 billion rupees versus 750.2 million rupees last year

BRIEF-Abbott India June-qtr profit down about 35 pct

* June quarter net profit 482.5 million rupees versus 740.1 million rupees last year

BRIEF-Abbott India March-qtr profit falls

* Net profit in March quarter last year was 589.9 million rupees as per IND-AS; total income was 7.02 billion rupees

BRIEF-Abbott India Dec-qtr profit rises

* Dec quarter total income from operations 7.56 billion rupees

BRIEF-Abbott India Sept qtr profit up about 23 pct

* Abbott India Ltd - sept quarter net profit 750.2 million rupees

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up